Figures & data
Table 1 Comparing characteristics of survey respondents with those of nonrespondents
Table 2 Comparing characteristics of commercially-insured survey respondents with those of Medicare-insured respondents
Figure 1 Distribution of respondents in the antihypertensive drug classes for Medicare-insured and commercially insured respondents.
Table 3 Barriers to adherence for Medicare-insured and commercially-insured survey respondents
Figure 2 Self-reported “other reasons” for nonadherence by Medicare-insured and commercially insured respondents.
Survey question: Can you tell me a little bit about why you missed your dose of the target drug that time? Responses to “other reasons”.
Table 4 Self-reported aids to overcoming adherence for Medicare-insured and commercially-insured survey respondents